<?xml version='1.0' encoding='utf-8'?>
<document id="27750346"><sentence text="[Medication management: Simvastatin and Amlodipin - a clinically relevant drug-interaction?]"><entity charOffset="24-35" id="DDI-PubMed.27750346.s1.e0" text="Simvastatin" /><entity charOffset="40-49" id="DDI-PubMed.27750346.s1.e1" text="Amlodipin" /><pair ddi="false" e1="DDI-PubMed.27750346.s1.e0" e2="DDI-PubMed.27750346.s1.e0" /><pair ddi="false" e1="DDI-PubMed.27750346.s1.e0" e2="DDI-PubMed.27750346.s1.e1" /></sentence><sentence text="The clinical relevance of the drug-drug interaction simvastatin and amlodipine is appraised controversially by german simvastatin Summary of Product Characteristics (SPCs) and different drug interaction databases"><entity charOffset="52-63" id="DDI-PubMed.27750346.s2.e0" text="simvastatin" /><entity charOffset="68-78" id="DDI-PubMed.27750346.s2.e1" text="amlodipine" /><entity charOffset="118-129" id="DDI-PubMed.27750346.s2.e2" text="simvastatin" /><pair ddi="false" e1="DDI-PubMed.27750346.s2.e0" e2="DDI-PubMed.27750346.s2.e0" /><pair ddi="false" e1="DDI-PubMed.27750346.s2.e0" e2="DDI-PubMed.27750346.s2.e1" /><pair ddi="false" e1="DDI-PubMed.27750346.s2.e0" e2="DDI-PubMed.27750346.s2.e2" /><pair ddi="false" e1="DDI-PubMed.27750346.s2.e1" e2="DDI-PubMed.27750346.s2.e1" /><pair ddi="false" e1="DDI-PubMed.27750346.s2.e1" e2="DDI-PubMed.27750346.s2.e2" /></sentence><sentence text=" Results of clinical trials have shown that simultaneous administration of simvastatin and amlodipine can increase simvastatin bioavailability"><entity charOffset="75-86" id="DDI-PubMed.27750346.s3.e0" text="simvastatin" /><entity charOffset="91-101" id="DDI-PubMed.27750346.s3.e1" text="amlodipine" /><entity charOffset="115-126" id="DDI-PubMed.27750346.s3.e2" text="simvastatin" /><pair ddi="false" e1="DDI-PubMed.27750346.s3.e0" e2="DDI-PubMed.27750346.s3.e0" /><pair ddi="false" e1="DDI-PubMed.27750346.s3.e0" e2="DDI-PubMed.27750346.s3.e1" /><pair ddi="false" e1="DDI-PubMed.27750346.s3.e0" e2="DDI-PubMed.27750346.s3.e2" /><pair ddi="false" e1="DDI-PubMed.27750346.s3.e1" e2="DDI-PubMed.27750346.s3.e1" /><pair ddi="false" e1="DDI-PubMed.27750346.s3.e1" e2="DDI-PubMed.27750346.s3.e2" /></sentence><sentence text=" However, it is unclear whether this increase is associated with a higher risk for adverse drug events" /><sentence text=" So far there is no evidence that the combination might increase cases of myopathy or rhabdomyolysis" /><sentence text=" Therefore combined treatment with amlodipine and up to 40 mg simvastatin daily seems clinically justifiable if the patient does not report adverse events"><entity charOffset="35-45" id="DDI-PubMed.27750346.s6.e0" text="amlodipine" /><entity charOffset="62-73" id="DDI-PubMed.27750346.s6.e1" text="simvastatin" /><pair ddi="false" e1="DDI-PubMed.27750346.s6.e0" e2="DDI-PubMed.27750346.s6.e0" /><pair ddi="false" e1="DDI-PubMed.27750346.s6.e0" e2="DDI-PubMed.27750346.s6.e1" /></sentence><sentence text=" If myopathy or muscle weakness occur, simvastatin dose should be reduced to 20 mg daily or the patient should be switched to pravastatin, fluvastatin or rosuvastatin"><entity charOffset="39-50" id="DDI-PubMed.27750346.s7.e0" text="simvastatin" /><entity charOffset="126-137" id="DDI-PubMed.27750346.s7.e1" text="pravastatin" /><entity charOffset="139-150" id="DDI-PubMed.27750346.s7.e2" text="fluvastatin" /><entity charOffset="154-166" id="DDI-PubMed.27750346.s7.e3" text="rosuvastatin" /><pair ddi="false" e1="DDI-PubMed.27750346.s7.e0" e2="DDI-PubMed.27750346.s7.e0" /><pair ddi="false" e1="DDI-PubMed.27750346.s7.e0" e2="DDI-PubMed.27750346.s7.e1" /><pair ddi="false" e1="DDI-PubMed.27750346.s7.e0" e2="DDI-PubMed.27750346.s7.e2" /><pair ddi="false" e1="DDI-PubMed.27750346.s7.e0" e2="DDI-PubMed.27750346.s7.e3" /><pair ddi="false" e1="DDI-PubMed.27750346.s7.e1" e2="DDI-PubMed.27750346.s7.e1" /><pair ddi="false" e1="DDI-PubMed.27750346.s7.e1" e2="DDI-PubMed.27750346.s7.e2" /><pair ddi="false" e1="DDI-PubMed.27750346.s7.e1" e2="DDI-PubMed.27750346.s7.e3" /><pair ddi="false" e1="DDI-PubMed.27750346.s7.e2" e2="DDI-PubMed.27750346.s7.e2" /><pair ddi="false" e1="DDI-PubMed.27750346.s7.e2" e2="DDI-PubMed.27750346.s7.e3" /></sentence><sentence text=" The highest approved dose of simvastatin (80 mg) is generally not recommended in new patients because of increased risk of muscle damage"><entity charOffset="30-41" id="DDI-PubMed.27750346.s8.e0" text="simvastatin" /></sentence><sentence text="" /></document>